Tyme Technologies, Inc.
TYME
|
$0.3107
-8.21%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (8.1% 2d) (18.4% 3d) (0.0% 7d) (-9.91% volume)
Earnings Calendar:
Market Cap: $ 53,504,682
http://www.tymeinc.com
Sec Filling | Patents | 18 employees
(United States) Tyme Technologies, Inc. is a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.
cancer t-cell ceiling
add to watch list Paper trade email alert is off
Press-releases
Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
Published: 2022-09-16 (Crawled : 22:00) - biospace.com/
MC | $50.97 -0.57% 0.0% 370K
|
Finance
|
| O: -1.22%
H: 0.82%
C: 0.75%
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 0.9%
H: 8.58%
C: 7.1%
SYRS | $4.76 -6.85% -7.35% 120K
|
Health Technology
|
| O: 2.76%
H: 0.04%
C: -1.95%
TYME TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME
Published: 2022-07-28 (Crawled : 03:00) - prnewswire.com
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: -2.2%
H: 5.16%
C: 2.81%
SYRS | $4.76 -6.85% -7.35% 120K
|
Health Technology
|
| O: 0.82%
H: 1.03%
C: -6.44%
alert
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RFP, LJPC, FSI, SYRS
Published: 2022-07-12 (Crawled : 18:00) - prnewswire.com
RFP | $21.92 0.0% 0
|
Process Industries
|
| O: -0.98%
H: 0.89%
C: -1.49%
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: -2.44%
H: 5.63%
C: 5.53%
SYRS | $4.76 -6.85% -7.35% 120K
|
Health Technology
|
| O: 0.17%
H: 0.64%
C: 0.39%
LJPC | $6.22 0.0%
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: 0.33%
INVA | $14.69 1.45% 1.43% 640K
|
Health Technology
|
| O: -3.27%
H: 1.44%
C: 0.94%
Investor Alert - The M&A Class Action Firm Announces an Investigation of Tyme Technologies, Inc. - TYME
Published: 2022-07-06 (Crawled : 01:00) - prnewswire.com
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: -15.94%
H: 1.4%
C: -10.75%
SYRS | $4.76 -6.85% -7.35% 120K
|
Health Technology
|
| O: 3.45%
H: 1.49%
C: -11.1%
alert
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
Published: 2022-07-05 (Crawled : 12:00) - biospace.com/
MC | $50.97 -0.57% 0.0% 370K
|
Finance
|
| O: -1.66%
H: 4.72%
C: 4.72%
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 24.6%
H: 0.0%
C: 0.0%
SYRS | $4.76 -6.85% -7.35% 120K
|
Health Technology
|
| O: 3.46%
H: 1.15%
C: -7.59%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 2.44%
H: 2.71%
C: 2.66%
Elevar Therapeutics Names Dr. Jan M. Van Tornout Chief Medical Officer, Dr. Gordon Schooley Chief Regulatory Officer
Published: 2022-06-28 (Crawled : 20:00) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: -7.31%
MBRX | News | $4.59 7.24% 6.75% 50K
|
Health Technology
|
| O: 0.68%
H: 1.52%
C: -2.01%
therapeutics
TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results-- $84.0 million in cash and marketable securities as of March 31, 2022 --
Published: 2022-05-25 (Crawled : 12:00) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: -3.48%
H: 0.95%
C: -7.62%
year
TYME Technologies, Inc. Announces Exploration of Strategic Options
Published: 2022-03-29 (Crawled : 11:00) - globenewswire.com
MC | $50.97 -0.57% 0.0% 370K
|
Finance
|
| O: 1.84%
H: 1.97%
C: 1.61%
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: -1.23%
H: 7.5%
C: 6.32%
TYME Technologies, Inc. Announces Changes to its Board of Directors
Published: 2022-03-25 (Crawled : 14:00) - biospace.com/
WST | $377.33 -0.01% 0.0% 320K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -1.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 4.6%
H: 2.79%
C: 1.11%
OSUR | $5.25 0.0% 660K
|
Health Technology
|
| O: 0.14%
H: 1.01%
C: -1.72%
TYME Technologies, Inc. Announces SM-88 Poster at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-03-09 (Crawled : 12:00) - globenewswire.com
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 4.35%
H: 4.83%
C: 4.0%
sm-88 america pos research cancer
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10